A comparison of three extrusion systems - I: The influence of water content and extrusion speed on pellet properties

Pharmaceutical Technology

Volumn 35, Issue 1, 2011, Pages 56-65

  Désiré, Amélie ^a   Paillard, Bruno ^b   Bougaret, Joël ^b   Baron, Michel ^a   Couarraze, Guy ^c  

^a ECOLE DES MINES D ALBI CARMAUX   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MICROCRYSTALLINE CELLULOSE;

ARTICLE; CONTROLLED STUDY; DRUG QUALITY; PARTICLE SIZE; PELLET EXTRUSION; PRODUCTIVITY; RESPONSE SURFACE METHOD; SPHERONIZATION; WATER CONTENT;

EID: 79952374865     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. R. Gandhi, C.L. Kaul, and R. Panchagnula, Pharm. Sci. Technol. Today 2 (4), 160-170 (1999).
2. K. Umprayn, P. Chitropas, and S. Amarekajorn, Drug Dev. Ind. Pharm. 25 (1), 45-61(1999).
3. N.R. Trivedi et al., Critical Rev. Ther. Drug Carrier Syst. 24 (1), 1-40 (2007).
4. C. Vervaet, L. Baert, and J.P. Remon, Int. J. Pharm. 116 (2), 131-146 (1995).
5. J.J. Sousa et al., Int. J. Pharm. 232 (1-2), 91-106 (2002).
6. L. Baert et al., Int. J. Pharm. 86 (2-3), 187-192 (1992).
7. K.E. Fielden, J.M. Newton, and R.C. Rowe, Int. J. Pharm. 81 (2-3), 225-233 (1992).
8. J. M. Newton, S. R. Chapman, and R. C. Rowe, Int. J. Pharm. 120 (1), 101-109 (1995).
9. L. Baert et al., Int. J. Pharm. 99 (1), 7-12. (1993).
10. C. Schmidt and P. Kleinebudde, Eur. J. Pharm. Biopharm. 45 (2), 173-179 (1998).
11. E. Nürnberg and J. Wunderlich, Pharm. Technol. Eur. 11 (3), 30-34 (1999).
12. K. Thoma and I. Ziegler, Drug Dev. Ind. Pharm. 24 (5), 401-411 (1998).
13. K. Thoma, and I. Ziegler, Drug Dev. Ind. Pharm. 24 (5), 413-422 (1998).
14. E. Le Doeuff et al., 6th International Conference of Pharmaceutical Technology (Paris, 1992).
15. D. Sonaglio, B. Bataille, and M. Jacob, Pharm. Acta Helv. 72 (2), 69-74 (1997).
16. D. Sonaglio et al., Pharmazie 52 (2), 129-134 (1997).
17. D. Djuric et al., Eur. J. Pharm. Biopharm. 71 (1), 155-160 (2009).
18. A. Debunne, C. Vervaet, and J.P. Remon, Eur. J. Pharm. Biopharm. 54 (3), 343-348 (2002).
19. A. Dukić et al., Eur. J. Pharm. Biopharm. 66 (1), 83-94 (2007).
20. H. Kanbe et al., Int. J. Pharm. 337 (1-2), 56-62 (2007).
21. A. Dukić-Ott et al., Eur. J. Pharm. Biopharm. 70 (1), 302-312 (2008).
22. K.E. Fielden, J.M. Newton, and R.C. Rowe, Int. J. Pharm. 97 (1-3), 79-92 (1993).
23. E. Jerwanska et al., Int. J. Pharm. 121 (1), 65-71 (1995).
24. J.J. Sousa et al., Int. J. Pharm. 144 (2), 159-169 (1996).
25. L. Hellén et al., J. Pharm. Tech. Int. 4 (9), 50-60 (1992).
26. G.A. Hileman et al., Int. J. Pharm. 100 (1-3), 71-79 (1993).
27. C.C. Ku et al., Drug Dev. Ind. Pharm. 19 (13), 1505-1519 (1993).
28. B. Bataille, K. Ligarski, and M. Jacob, Pharm. Acta Helv. 65 (12), 334-337 (1990).
29. D. Sonaglio et al., Int. J. Pharm. 115 (1), 53-60 (1995).
30. K.A. Mehta et al., J. Control. Release 63 (1-2), 201-211 (2000).
31. S. Galland et al., Chem. Eng. Res. Des. 81 (9), 1237-1242 (2003).
32. S. Galland et al., Powder Technol. 157 (1-3), 156-162 (2005).
33. P. Kleinebudde and H. Lindner, Int. J. Pharm. 94 (1-3), 49-58 (1993).
34. D. Lutchman, C.M. Dangor, and D. Perumal, J. Microencapsul. 22 (6), 643-659 (2005).
35. C. Vervaet et al., Int. J. Pharm. 107 (1), 29-39 (1994).
36. C. Vervaet and J.P. Remon, Int. J. Pharm. 133 (1-2), 29-37 (1996).
37. R. Dietrich and R. Brausse, Pharm. Ind. 50 (10), 1179-1186 (1988).